Rafael Holdings IncNYSE:RFL
- LAST PRICE1.8800
- TODAY'S CHANGE (%)0.0200 (1.0753%)
- Bid / Lots1.8800/ 2
- Ask / Lots1.9500/ 20
- Open / Previous Close1.8700 / 1.8600
- Day Range
- 52 Week Range
- Volume23,196
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RFL |
|---|---|---|
| 09:32 ET | 1895 | 1.87 |
| 10:02 ET | 5000 | 1.8895 |
| 10:09 ET | 2906 | 1.87 |
| 11:05 ET | 9462 | 1.8701 |
| 11:39 ET | 100 | 1.87 |
| 12:08 ET | 811 | 1.88 |
| 12:17 ET | 1439 | 1.87 |
| 12:50 ET | 572 | 1.88 |
| 01:00 ET | 572 | 1.88 |
Nov 6, 2024
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results, from 7:14PM ET on Wednesday Nov 06, 2024 by Dow Jones
7:14PM ET on Wednesday Nov 06, 2024 by Dow Jones*DJ Rafael Holdings 4Q Rev $165,000 >RFL, from 7:14PM ET on Wednesday Nov 06, 2024 by Dow Jones
7:14PM ET on Wednesday Nov 06, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Rafael Holdings Inc | 45.9M | -1.3x | --- |
Envoy Medical Inc | 46.4M | -1.7x | --- |
Harvard Apparatus Regenerative Technology Inc | 47.6M | -5.1x | --- |
Vivos Inc | 38.6M | -11.9x | --- |
Nexalin Technology Inc | 54.9M | -6.5x | --- |
Adagio Medical Holdings Inc | 37.1M | -14.3x | --- |
Company Information
Rafael Holdings, Inc. is a holding company with interests in clinical and early-stage pharmaceutical companies. Its segments include Healthcare, Infusion Technology and Real Estate. It holds a majority equity interest in LipoMedix Pharmaceuticals Ltd. (a clinical-stage pharmaceutical company), Barer Institute Inc. (a preclinical cancer metabolism research operation), and a majority interest in Cornerstone Pharmaceuticals, Inc. (a cancer metabolism-based therapeutics company). It holds a majority interest in Rafael Medical Devices, LLC., an orthopedic-focused medical device company, and a majority interest in Day Three Labs, Inc., a company which empowers third-party manufacturers to reimagine their cannabis offerings enabling them to bring to market predictable versions by utilizing Day Three's pharmaceutical-grade technology and innovation like Unlokt. Its investments include Cyclo Therapeutics Inc. (developing Trappsol Cyclo). It holds a portion of a commercial building in Israel.
Contact Information
- Headquarters
- 520 Broad StreetNEWARK, NJ, United States 07120
- Phone
- 212-658-1450
- Fax
- 302-636-5454
Executives
- Executive Chairman of the Board
- Howard Jonas
- President, Chief Executive Officer
- William Conkling
- Chief Financial Officer
- David Polinsky
- Chief Medical Officer
- John Goldberg
- Lead Independent Director
- Stephen Greenberg
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $45.9M |
|---|---|
Revenue (TTM) | $637.0K |
Shares Outstanding | 24.7M |
Rafael Holdings Inc does not pay a dividend. | |
Beta | 1.07 |
EPS | $-1.45 |
Book Value | $3.34 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | 72.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -16,367.35% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
